News
Why Walt Disney Co. Shares Fell 5% Today
Walt Disney (NYSE: DIS) shares traded lower on Wednesday, following the release of third-quarter results and the announcement of a new push into streaming-video services. The multi-year contract with
Why Tucows Inc. Stock Jumped 12% Today
Shares of network service provider Tucows (NASDAQ: TCX) jumped as much as 12.2% higher on Wednesday, driven by Tuesday night's second-quarter earnings report.The report was actually not a home run
Here's Why Ultra Petroleum Corp. Is Plunging Today
Shares of Ultra Petroleum Corp. (NASDAQ: UPL) slumped on Wednesday and were down more than 13% at 2:45 p.m. EDT, after the company posted mixed second-quarter results.On the plus side, Ultra Petroleum
Here's Why AmTrust Financial Services Stock Is Falling Today
Property-casualty insurance company AmTrust Financial Services (NASDAQ: AFSI) reported second-quarter earnings that came in short of analysts' estimates and fell by 48% year over year. The miss was
This Little-Known Healthcare Stock Could Be the Tesla of Its Niche
In less than 15 years, Elon Musk and the team at Tesla (NASDAQ: TSLA) have accomplished something that few could have predicted: They redefined how Americans viewed electric cars. Along the way, the
Why Vitamin Shoppe Stock Got Destroyed Today
Shares of Vitamin Shoppe (NYSE: VSI) have gotten destroyed today, down by 35% as of 2:30 p.m. EDT, after the company reported disappointing second-quarter earnings.Revenue in the second quarter fell
The Sole Reason Amicus Therapeutics, Inc. Exploded 29% Higher in July
Shares of Amicus Therapeutics (NASDAQ: FOLD), a biopharmaceutical company focused on the development rare-disease drugs, exploded higher by 29% during the month of July, according to data from S&P
Why Hertz Global Holdings, Inc. Stock Jumped Wednesday
Shares of Hertz Global (NYSE: HTZ) jumped as much as 26% on Wednesday, following the release of the car rental company's second-quarter earnings. The stock is up about 25% at the time of this writing.
Big Oil Is Planning to Produce at $50 Forever
Last week, Shell (NYSE: RDS-A) (NYSE: RDS-B) and BP (NYSE: BP) made headlines by announcing that they plan to produce oil at $50 a barrel forever, and many of the other big players are planning to
Pioneer Natural Resources Was Down 13% Overnight
Pioneer Natural Resources (NYSE: PXD) has been one of the best exploration and production companies in the business, but this quarter's earnings report has a lot of investors second-guessing whether
Polarizing Results for Two Solar Companies
First Solar (NASDAQ: FSLR) and SunPower (NASDAQ: SPWR) reported earnings last week, and the market sent the stocks flying by double digits in opposite directions.In this Industry Focus segment, Motley
Vivint Solar Making Successful Transition to Solar Sales
Slowing down to reduce costs and focus on more profitable customers seems to be working well for residential solar installers like Vivint Solar (NYSE: VSLR) and Sunrun (NASDAQ: RUN). Costs are down
Earnings Preview: Did Nordstrom and J.C. Penney Return to Comp Sales Growth in Q2?
Three months ago, department store stocks got crushed after a series of subpar earnings reports. Comparable-store sales declined at every major department store company in the first quarter of fiscal
5 Best Platinum Stocks to Buy Right Now
Materials scientists still haven't found a better catalyst than platinum group metals, or PGMs. That means platinum stocks -- not all of which are platinum mining stocks -- will continue to offer
More Evidence That Apple's "iPhone 8" Could Launch on Time
Apple (NASDAQ: AAPL) investors have been feeling rather confident about the company's prospects following a solid fiscal third-quarter earnings report. In particular, the Mac maker's guidance for the
Here's Why Surgery Partners Inc. Is Sinking Today
Shares of Surgery Partners Inc. (NASDAQ: SGRY), a provider of surgical care services, tanked 52% shortly after the opening bell this morning in response to an earnings miss on the top and bottom
Why Zillow Group Inc. Stock Plunged Today
Shares of Zillow Group Inc. (NASDAQ: Z) (NASDAQ: ZG) were down 9.8% as of 1:30 p.m. EDT Wednesday after the online real estate platform company announced strong second-quarter results, but followed
The 1 Very Clear Reason Arena Pharmaceuticals, Inc. Skyrocketed 41% in July
Shares of Arena Pharmaceuticals (NASDAQ: ARNA), a biopharmaceutical company focused on the development of small-molecule drugs for the treatment of a variety of diseases, catapulted 41% during July
Sunrun Sticks to 2017 Growth Plans
Sunrun (NASDAQ: RUN) continues to be the only major residential solar installer with its foot on the growth pedal as its other major competitors tap the brakes. Tesla (NASDAQ: TSLA) has decided to
What’s New in BDC Land: Golub Capital, Ares Capital and Monroe Capital Corp.
It's earnings season for a little-followed niche of the financial market: business development companies. From billion-dollar giants like Golub Capital BDC (NASDAQ: GBDC) and Ares Capital (NASDAQ:
U10 - Nombre total de droits de vote et d'actions au 31 juillet 2017
Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Article 223-16 du Règlement Général de l'Autorité des Marchés....
Don't Be Fooled: Chipotle and Under Armour Aren't Cheap
Chipotle Mexican Grill, Inc. (NYSE: CMG) and Under Armour Inc. (NYSE: UA) (NYSE: UAA) may compete in different industries, but the two stocks have been fellow travelers on the stock market throughout
Why TripAdvisor Inc Stock Slumped Today
Shares of TripAdvisor Inc. (NASDAQ: TRIP) were pulling back today after the travel services company reported another underwhelming earnings report and gave weak guidance.As of 11:18 a.m. EDT, the
Why Arcos Dorados Holdings Inc. Gained 18% Last Month
Shares of Arcos Dorados Holdings Inc. (NYSE: ARCO) jumped again last month, gaining on a strong earnings report for its franchisor and on anticipation of its own second-quarter earnings report.Image
Here's Why Acadia Pharmaceuticals Inc. Is Soaring Today
In response to Acadia Pharmaceuticals (NASDAQ: ACAD) reporting blow-out earnings and sharing upbeat guidance, shares of the commercial-stage biopharma, which focuses on diseases of the central nervous